Skip To Main Content
Barbara Judy on Muck Rack

Barbara Judy

As seen in: The Journal of Allergy & Clinical Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The arrival of SARS-CoV-2-neutralizing antibodies in a currently available commercial immunoglobulin

|
By Aaron Miller, Aaron Miller, Nicholas L. Rider, Richard B. Pyles, Barbara Judy, Xuping Xie, Pei-Yong Shi, Thomas G. Ksiazek
| The Journal of Allergy & Clinical Immunology Verified
To the Editor: The coronavirus disease 2019 (COVID-19) pandemic has heightened awareness of the primary immunodeficiency/inborn errors of immunity community, and its impact on those with immunodeficiency diseases has been reported recently. 1 Meyts I. Bucciol G. Quinti I. Neven B. Fischer A. Seoane E. et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol.
Open in Who Shared Issue with article?
See all 1 articles